Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas-Reference-Cited by-同舟云学术

Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

Published:2013-12-12 Issue:3 Volume:16 Page:400-408
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Alentorn Agustí,van Thuijl Hinke F.,Marie Yannick,Alshehhi Hussa,Carpentier Catherine,Boisselier Blandine,Laigle-Donadey Florence,Mokhtari Karima,Scheinin Ilari,Wesseling Pieter,Ylstra Bauke,Capelle Laurent,Hoang-Xuan Khê,Sanson Marc,Delattre Jean-Yves,Reijneveld Jaap C.,Idbaih Ahmed

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/16/3/400/16664491/not227.pdf

Reference34 articles.

1. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas;Smith;J Clin Oncol.,2000

2. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas;Ohgaki;J Neuropathol Exp Neurol.,2005

3. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas;Coons;Cancer.,1997

4. Update on molecular findings, management and outcome in low-grade gliomas;Bourne;Nat Rev Neurol,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review;European Journal of Cancer;2022-11

2. Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma;Frontiers in Pharmacology;2022-08-31

3. Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma;Cochrane Database of Systematic Reviews;2022-03-02

4. Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas;Archives of Pathology & Laboratory Medicine;2022-02-17

5. TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy;Cancers;2021-10-26